Profil
George A. Thampy currently works at Concentric Equity Partners, as Associate from 2012.
Mr. Thampy also formerly worked at William Blair & Co. LLC, as Analyst in 2011 and Kyverna Therapeutics, Inc., as Head-Investor Relations.
Mr. Thampy received his undergraduate degree in 2010 from Harvard University.
Postes actifs de George A. Thampy
| Sociétés | Poste | Début |
|---|---|---|
Concentric Equity Partners
Concentric Equity Partners Investment ManagersFinance Concentric Equity Partners invests in companies located in the United States and Asia. The firm focuses on business & consumer services, tech-enabled services, banks, insurance services, value added distribution and niche manufacturing. It participates in buyout, MBOs, LBOs and also acquires majority and minority interest. | Analyste en capital-investissement | 01/01/2012 |
Anciens postes connus de George A. Thampy
| Sociétés | Poste | Fin |
|---|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 31/12/2011 |
| KYVERNA THERAPEUTICS, INC. | Investor Relations Contact | - |
Formation de George A. Thampy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Concentric Equity Partners
Concentric Equity Partners Investment ManagersFinance Concentric Equity Partners invests in companies located in the United States and Asia. The firm focuses on business & consumer services, tech-enabled services, banks, insurance services, value added distribution and niche manufacturing. It participates in buyout, MBOs, LBOs and also acquires majority and minority interest. | Finance |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
















